PATENT CLAIM ANALYSIS

Application Number: 15947741
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["435", "455000"]

Abstract:
The present invention relates in pan to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.

Claim (Index 25):
The method of  claim 18 , wherein the medium is substantially free of immunosuppressants.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 91.0
- Lexical Diversity: 1.55172
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15358818', '15605513', '15178190', '13465490', '14810123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6846656166050202
- 35 USC 102 Novelty (BERT): 0.5485667322900407
- Combined Prediction Score: 0.6710557281735223
- Mean Citation Score: 379.825306
- Max Citation Score: 381.86386
- Similarity Product: 257.76974085149294

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test